Hatim Karachiwala

436 citations
21 papers · 147 indexed · 1 hit paper · h-index 6
Topics
Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Colorectal Cancer Treatments and Studies (6 papers)Gastric Cancer Management and Outcomes (4 papers)
Partner nations
CanadaUnited StatesJapan

In The Last Decade

Hatim Karachiwala

18 papers receiving 146 citations

Hit Papers

Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN...2024202620252024255075

Peers

Hatim Karachiwala
Comparison fields: 5 of 38
  • Hepatology 79
  • Oncology 58
  • Epidemiology 45
  • Pulmonary and Respiratory Medicine 37
  • Pathology and Forensic Medicine 21
Replace Maria Flores with:
Maria Flores Italy
Jian-qiang Cai China
Răzvan Grigorie Romania
David W.G. ten Cate Netherlands
Ann‐Shing Lee China
Kazuki Ohya Japan
Peter R. Galle Germany
Juri Fuchs Germany
Daniele Ferraro Italy
Elsayed Mostafa Ali Egypt
Hatim Karachiwala relative to Maria Flores Italy Maria Flores's profile →
Citations per field
00.5×3.0×
Maria Flores · 1×
Citations per year

Countries citing papers authored by Hatim Karachiwala

Since Specialization
Citations

This map shows the geographic impact of Hatim Karachiwala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatim Karachiwala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatim Karachiwala more than expected).

Fields of papers citing papers by Hatim Karachiwala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatim Karachiwala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatim Karachiwala. The network helps show where Hatim Karachiwala may publish in the future.

Co-authorship network of co-authors of Hatim Karachiwala

This figure shows the co-authorship network connecting the top 25 collaborators of Hatim Karachiwala. A scholar is included among the top collaborators of Hatim Karachiwala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatim Karachiwala. Hatim Karachiwala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.breakdown →
75
4 1
5 7
6 6
7 0
8 1
9 2
10 3
11 0
12 1
13 4
14 1
15 5
16 16
17 1
18 4
19 12
20 1

About Hatim Karachiwala

Hatim Karachiwala is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 147 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Hepatology (79 citations), Oncology (58 citations) and Epidemiology (45 citations). Hatim Karachiwala has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Omar Abdel‐Rahman, Qi Wang, Joseph Hreiki, Matthias Pinter, Chang‐Fang Chiu, Gonzalo Pizarro, David Tai, Aiwu Ruth He, Peter R. Galle and Armando Santoro. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026